Significant Wealth Partners LLC grew its position in OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report) by 36.1% in the 2nd quarter, Holdings Channel.com reports. The firm owned 36,837 shares of the medical instruments supplier’s stock after buying an additional 9,770 shares during the period. Significant Wealth Partners LLC’s holdings in OraSure Technologies were worth $111,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Farther Finance Advisors LLC bought a new position in OraSure Technologies in the 2nd quarter worth about $26,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in OraSure Technologies in the 1st quarter worth about $49,000. Amundi bought a new position in OraSure Technologies in the 1st quarter worth about $47,000. Quantbot Technologies LP bought a new position in shares of OraSure Technologies in the first quarter valued at approximately $52,000. Finally, Simplicity Wealth LLC bought a new position in shares of OraSure Technologies in the first quarter valued at approximately $53,000. Institutional investors own 93.50% of the company’s stock.
OraSure Technologies Price Performance
OraSure Technologies stock opened at $3.23 on Thursday. The firm has a 50 day simple moving average of $3.15 and a 200-day simple moving average of $3.06. The stock has a market capitalization of $236.23 million, a PE ratio of -4.82 and a beta of 0.44. OraSure Technologies, Inc. has a 12-month low of $2.36 and a 12-month high of $4.60.
OraSure Technologies Profile
OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Featured Stories
- Five stocks we like better than OraSure Technologies
- What is a buyback in stocks? A comprehensive guide for investors
- Cybersecurity Market Set to Double: This ETF Offers Exposure
- How to Read Stock Charts for Beginners
- Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
- Expert Stock Trading Psychology Tips
- Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report).
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
